171 – 180 of 340
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcome.
(
- Contribution to journal › Article
-
Mark
Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations
(
- Contribution to journal › Article
-
Mark
The Target for Statins, HMG-CoA Reductase, Is Expressed in Ductal Carcinoma-In Situ and May Predict Patient Response to Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Primary Melanoma Tumors from CDKN2A Mutation Carriers do not Belong to a Distinct Molecular Subclass.
(
- Contribution to journal › Article
-
Mark
Peroxiredoxin-1 protects estrogen receptor alpha from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
(
- Contribution to journal › Article
-
Mark
Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival - results from the EPIC cohort study.
(
- Contribution to journal › Article
-
Mark
A systematic analysis of commonly used antibodies in cancer diagnostics
(
- Contribution to journal › Article
-
Mark
Molecular and genetic diversity in the metastatic process of melanoma.
(
- Contribution to journal › Article
-
Mark
Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study.
(
- Contribution to journal › Article